MRD / Regn No. : SG001006 Date : 20/07/2026
Patient Name : ARINDAM NANDI Age & Gender : 53 Yrs. / Male
Contact No. : 9434135140 UHID :
Ht / Wt / BMI : 160 / 77 / 30.08 BP S / BP D : 146 / 86
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (25/Mar/2016) | HYPERTENSION (25/Mar/2023) | DYSLIPIDEMIA (25/Mar/2023) | CAD (20/Jul/2026) |
Salient Investigations : CREATININE: 0.77 | EGFR EGLOMERULAR FILTRATION RATE: 112.59 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 124 mg/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 9 % | MICROALBUMIN CREATININE RATIO: 106.9 mcg/mg | NTPROBNP : 31 | POST PRANDIAL GLUCOSE (2HPP): 211 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 GLIMEPIRIDE 4 MG + METFORMIN 1000 MG
GLYCOMET GP 4 FORTE 		PO 1-0-0 BEFORE BREAKFAST
 TILL NEXT VISIT
2 ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG
APDA 10 MG 		PO 1-0-0 BEFORE BREAKFAST
 TILL NEXT VISIT
3 ANTIHYPERGLYCEMIC SEMAGLUTIDE 0.25 MG
SEMASIZE 0.25 MG 		SC ONCE A WEEK AFTER BREAKFAST
 TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 20/Jan/2027
Tests Suggested For Next Visit : CHECK FASTING AND PP SUGAR AFTER 4 WEEKS AND INFORM,HBA1C-HPLC METHOD,RETINA CHECK UP,UACR:SPOT SAMPLE
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: